{# ── Non-reliance notice. Reaching the live report with one of these means it did not meet the blocking bar (the 4.02 names this period outside the Item 4.02 body) or the viewer is staff. Either way the reader must not take the figures at face value. ── #}

Get notified when TLRY files again. Create a free account and we'll email you the moment its next filing is analyzed.

Get filing alerts

Standing Risk Factors

  • Cryptocurrency Treasury Strategy (unchanged) — Filing discloses a named Bitcoin treasury/financing strategy. On minimal cash with going-concern doubt, this non-standard treasury pivot is material.
NASDAQ: TLRY Tilray Brands, Inc. 10-K

Tilray completes BrewDog, Lyphe acquisitions; U.S. cannabis rescheduling advances; adjusted EBITDA rises to $61.1M

Filed July 28, 2026 · Period ending May 31, 2026 · Compared to 10-K Jul 29, 2025 · ~2 min read

Key Changes

  • high

    BrewDog acquisition (March–April 2026) transformed beverage segment from U.S. to global platform, adding U.K./Australia brewing, 35 pubs/hotels, and international distribution for U.S. brands. Lyphe acquisition (April 2026) added U.K. medical cannabis clinic and digital pharmacy.

    Business: BrewDog & Lyphe Acquisitions verify on EDGAR →
  • high

    U.S. DOJ rescheduled FDA-approved and state-licensed medical cannabis to Schedule III (April 2026); DEA administrative hearing ongoing with legal challenges. Tilray positioned to participate in federally compliant U.S. medical cannabis market but outcome uncertain.

    Business: U.S. Cannabis Rescheduling verify on EDGAR →
  • high

    Adjusted EBITDA increased $6.1M to $61.1M in FY2026 from $ 915,454 in FY2025 as company executed strategic plan. Operating cash flow improved: net cash used fell from $94.6M to $69.1M; excluding working capital, operating cash flow positive $18.2M vs. cash used $32.0M prior year.

    MD&A: Adjusted EBITDA & Operating Cash Flow verify on EDGAR →

2 more material changes behind this preview — plus the full narrative summary, section-by-section diffs against the prior filing, and verbatim quotes with EDGAR citations.

Read 3 full reports/month free No card required. Takes 30 seconds.

Want to see a complete report first? Today's free report (IMMR 10-K) is open in full — no account needed.

Partner

Trade TLRY commission-free

Open an account, get a free stock.

Sign up

Investing involves risk. Free stock terms apply.

Was this report useful?
View original filing on SEC.gov View full financials on EDGAR ↗

Source-verified from EDGAR · Narrative written by AI · Jul 29, 2026 · How we verify